Immunotherapy

ROCKVILLE, MD — November 20, 2025 — OS Therapies announced the strategic spin-off of OS Animal Health, establishing it...

Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...

Dateline: November 17, 2025 — New York, NYOS Therapies reported its third-quarter 2025 financial results and issued a comprehensive...

NEW YORK, November 6, 2025 — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing gamma-delta (γδ) T cell...

MINNEAPOLIS, USA, and TEL AVIV, Israel, November 4, 2025 — Bio-Techne Corporation (NASDAQ: TECH) and Nucleai, an AI-driven precision-medicine...

CALGARY, Alberta, November 4, 2025 — Oncolytics Biotech® Inc. (NASDAQ: ONCY; TSX: ONC) announced the formation of a Gastrointestinal...

Phoenix, AZ | October 27, 2025 – Johnson & Johnson’s TREMFYA® (guselkumab) becomes the first and only IL-23 inhibitor...

Marlborough, MA – October 17, 2025 – Boston Scientific Corporation announced that it has entered into a definitive agreement...

Paris, France – October 16, 2025 – The U.S. Food and Drug Administration (FDA) has granted Fast Track designation...

October 14, 2025 | Düsseldorf, Germany — Abalos Therapeutics announced the publication of preclinical proof-of-concept data in Cell Reports...